Products
Platform
Research
Market
Learn
Compare DSP Nifty Healthcare Index Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 0.94 | 1.93 |
NAV | ₹10.40 | ₹434.58 |
Fund Started | 02 Jun 2025 | 04 Jun 1999 |
Fund Size | ₹12.93 Cr | ₹3933.26 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
0.94
1.93
NAV
₹10.40
₹434.58
Fund Started
02 Jun 2025
04 Jun 1999
Fund Size
₹12.93 Cr
₹3933.26 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | - | 2.53% |
3 Year | - | 24.41% |
5 Year | - | 19.99% |
1 Year
-
2.53%
3 Year
-
24.41%
5 Year
-
19.99%
Holding Analysis
Equity | 99.32% | 96.36% |
Cash | 0.68% | 3.56% |
Equity
99.32%
96.36%
Cash
0.68%
3.56%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 17.67% |
Cipla Ltd. | 8.89% |
Max Healthcare Institute Ltd. | 8.71% |
Apollo Hospitals Enterprise Ltd. | 7.87% |
Dr. Reddy's Laboratories Ltd. | 7.84% |
Divi's Laboratories Ltd. | 7.60% |
Fortis Healthcare Ltd. | 5.31% |
Lupin Ltd. | 4.86% |
Torrent Pharmaceuticals Ltd. | 3.96% |
Laurus Labs Ltd. | 3.44% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.94% |
Divi's Laboratories Ltd. | 6.36% |
Max Healthcare Institute Ltd. | 5.67% |
Cipla Ltd. | 4.59% |
Lupin Ltd. | 4.08% |
Lonza Group Ag | 4.06% |
Fortis Healthcare Ltd. | 3.70% |
Torrent Pharmaceuticals Ltd. | 3.66% |
Gland Pharma Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.34% |
Fund Manager
Name | Anil Ghelani | Tanmaya Desai |
Start Date | 08 Aug 2025 | 17 May 2024 |
Name
Anil Ghelani
Tanmaya Desai
Start Date
08 Aug 2025
17 May 2024
About Fund
Description | The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 02 Jun 2025 | 04 Jun 1999 |
Description
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
02 Jun 2025
04 Jun 1999